EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alpha‐Mangostin Alleviates Mitochondrial Damage and Autophagy Dysregulation in the MPP + Cellular Model of Parkinson’s Disease

Korede Jacob Abraham, Permphan Dharmasaroja iD

Advances in Pharmacological and Pharmaceutical Sciences · 2025-01 · 2025 (1)

DOI: 10.1155/adpp/5567858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 18.08.2025. Verfasst von Korede Jacob Abraham und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha‐mangostin (α‐M), a xanthone derivative with known antioxidative properties, has demonstrated a protective effect on neurons under oxidative stress, a key factor in the pathogenesis of Parkinson’s disease (PD). However, its impact on mitochondrial integrity and autophagy in PD remains insufficiently understood. Therefore, the present study aimed to investigate the role of α‐M in regulating defective mitochondrial proteins and its influence on the mTOR pathway, both of which are critical in the regulation of autophagy. This study investigated the effects of α‐M pretreatment on 1‐methyl‐4‐phenylpyridinium (MPP + )‐induced neurotoxicity in SH‐SY5Y dopaminergic neurons. MPP + , a mitochondrial complex I inhibitor, significantly reduced the expression of mitochondrial proteins NDUFS3 and TIMM23, induced mitochondrial damage, and triggered excessive autophagy, as evidenced by elevated LC3‐II/LC3‐I ratio and phospho‐Beclin‐1 expression. These changes were accompanied by dysregulation of the mTOR signaling pathway, including increased phosphorylation of mTOR and suppression of its downstream effector p70S6K. α‐M pretreatment restored NDUFS3 and TIMM23 levels, preserved mitochondrial morphology and membrane potential, and reduced autophagy activation by mitigating MPP + ‐induced LC3B accumulation and Beclin‐1 activation. Additionally, α‐M restored balance in the mTOR signaling pathway by reducing mTOR phosphorylation and restoring p70S6K activity, counteracting the autophagic dysregulation caused by MPP + . Importantly, α‐M exhibited no toxicity under normal conditions, indicating its protective effects are context‐dependent and activated only during cellular stress. These findings highlight the potential of α‐M as a therapeutic agent for PD, providing neuroprotection through its targeted modulation of mitochondrial proteins and mTOR signaling that regulates autophagy.

Schlagwörter

Stichwörter der Autor:innen

MPP+alpha-mangostinautophagymTORmitochondriap70S6K

Autor:innen und Institutionen

  • Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Permphan Dharmasaroja

Förderung

  • Mahidol University

Zitieren

APA

Abraham, K. J., & Dharmasaroja, P. (2025). Alpha‐Mangostin Alleviates Mitochondrial Damage and Autophagy Dysregulation in the MPP + Cellular Model of Parkinson’s Disease. Advances in Pharmacological and Pharmaceutical Sciences, 2025(1). https://doi.org/10.1155/adpp/5567858

Vancouver

Abraham KJ, Dharmasaroja P. Alpha‐Mangostin Alleviates Mitochondrial Damage and Autophagy Dysregulation in the MPP + Cellular Model of Parkinson’s Disease. Advances in Pharmacological and Pharmaceutical Sciences. 2025;2025(1). doi:10.1155/adpp/5567858

BibTeX
@article{Abraham2025,
  author = {Abraham, Korede Jacob and Dharmasaroja, Permphan},
  title = {Alpha‐Mangostin Alleviates Mitochondrial Damage and Autophagy Dysregulation in the MPP + Cellular Model of Parkinson’s Disease},
  journal = {Advances in Pharmacological and Pharmaceutical Sciences},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/adpp/5567858}
}
Kostenlos starten →